Interaction of 5 HT1B/D ligands with recombinant h 5-HT1A receptors:: Intrinsic activity and modulation by G-protein activation state

被引:18
作者
Pauwels, PJ [1 ]
Palmier, C [1 ]
Dupuis, DS [1 ]
Colpaert, FC [1 ]
机构
[1] Ctr Rech Pierre Fabre, Dept Mol & Cellular Biol, F-81106 Castres, France
关键词
recombinant h 5-HT1A receptor; S-35]GTP gamma S binding response; 5-HT1B/D agonists; ligand efficacy; C6-glial and HeLa cell lines;
D O I
10.1007/PL00005198
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many 5-HT1B/D receptor ligands have affinity for 5-HT1A receptors. In the present study, the intrinsic activity of a series of 5-HT1B/D ligands was investigated at human 5-HT1A (h 5-HT1A) receptors by measuring G-protein activation in recombinant C6-glial and HeLa membranes, using agonist-stimulated [S-35]GTP gamma S binding. In these two mem brane preparations, the density of h 5-HT1A receptors (i.e., 246 to 320 fmol mg(-1) protein) and of their G-proteins, and the receptor: G-protein density ratio (0.08 to 0.18) appeared to be similar. It was found that: (i) the maximal [S-35]GTP gamma S binding responses induced by the 5-HT1B/D receptor ligands in the HeLa preparation at 30 mu M GDP were comparable to that of the native agonist 5-HT; (ii) as compared to 5-HT (1.00), similar potencies but lower maximal responses were observed in the C6-glial preparation at 0.3 mu M GDP for zolmitriptan (0.89), dihydroergotamine (0.81), rizatriptan (0.71), CP122638 (0.69), naratriptan (0.60) and sumatriptan (0.53); and that (iii) maximal [S-35]GTP gamma S binding responses induced by 5-HT1B/D ligands in the C6-glial preparation were either unaffected or significantly enhanced by increasing the GDP concentration from 0.3 to 30 mu M and higher concentrations. These features differ from those observed with 5-HT1A receptor agonists; the latter display the same rank order of potency and efficacy in both membrane preparations, and increasing the amount of GDP with CG-glial membranes results in an attenuation of both the agonist's maximal effect and the apparent potency of partial agonists. The differential regulation of 5-HT1A and 5-HT1B/D agonist responses by GDP suggests that different G-protein subtypes are involved upon 5-HT1A receptor activation by 5-HT1A and 5-HT1B/D agonists.
引用
收藏
页码:490 / 499
页数:10
相关论文
共 35 条
[11]   [H-3]8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN BINDING TO PRESYNAPTIC AND POSTSYNAPTIC 5-HYDROXYTRYPTAMINE SITES IN VARIOUS REGIONS OF THE RAT-BRAIN [J].
HALL, MD ;
ELMESTIKAWY, S ;
EMERIT, MB ;
PICHAT, L ;
HAMON, M ;
GOZLAN, H .
JOURNAL OF NEUROCHEMISTRY, 1985, 44 (06) :1685-1696
[12]   MODULATION OF 5-HYDROXYTRYPTAMINE1A RECEPTOR DENSITY BY NONHYDROLYZABLE GTP ANALOGS [J].
HARRINGTON, MA ;
PEROUTKA, SJ .
JOURNAL OF NEUROCHEMISTRY, 1990, 54 (01) :294-299
[13]   5-HYDROXYTRYPTAMINE1A RECEPTORS ARE LINKED TO A GI-ADENYLATE CYCLASE COMPLEX IN RAT HIPPOCAMPUS [J].
HARRINGTON, MA ;
OKSENBERG, D ;
PEROUTKA, SJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (01) :95-98
[14]   8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN, 8-OH-DPAT, A POTENT AND SELECTIVE SIMPLIFIED ERGOT CONGENER WITH CENTRAL 5-HT-RECEPTOR STIMULATING ACTIVITY [J].
HJORTH, S ;
CARLSSON, A ;
LINDBERG, P ;
SANCHEZ, D ;
WIKSTROM, H ;
ARVIDSSON, LE ;
HACKSELL, U ;
NILSSON, JLG .
JOURNAL OF NEURAL TRANSMISSION, 1982, 55 (03) :169-188
[15]  
HOYER D, 1994, PHARMACOL REV, V46, P157
[16]   MOLECULAR-BIOLOGY OF SEROTONIN RECEPTORS [J].
JULIUS, D .
ANNUAL REVIEW OF NEUROSCIENCE, 1991, 14 :335-360
[17]   A conserved threonine residue in the second intracellular loop of the 5-hydroxytryptamine 1A receptor directs signaling specificity [J].
Lembo, PMC ;
Ghahremani, MH ;
Morris, SJ ;
Albert, PR .
MOLECULAR PHARMACOLOGY, 1997, 52 (01) :164-171
[18]  
LIU YF, 1991, J BIOL CHEM, V266, P23689
[19]  
MCLOUGHLIN DJ, 1997, BR J PHARM S, V120, pP236
[20]  
MILLIGAN G, 1988, BIOCHEM J, V255, P1